tradingkey.logo

Lifecore Biomedical Inc

LFCR
6.850USD
+0.230+3.47%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
256.64MCap. mercado
PérdidaP/E TTM

Lifecore Biomedical Inc

6.850
+0.230+3.47%

Más Datos de Lifecore Biomedical Inc Compañía

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Información de Lifecore Biomedical Inc

Símbolo de cotizaciónLFCR
Nombre de la empresaLifecore Biomedical Inc
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoMr. Paul Josephs
Número de empleados406
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 15
Dirección3515 Lyman Boulevard
CiudadCHASKA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55318
Teléfono19523684300
Sitio Webhttps://www.lifecore.com/
Símbolo de cotizaciónLFCR
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoMr. Paul Josephs

Ejecutivos de Lifecore Biomedical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
Investor Relations
Investor Relations
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 4 de mar
Divisa: USDActualizado: mar., 4 de mar
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
Otro
1.50M
5.43%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%

Estadísticas de accionistas

Actualizado: sáb., 20 de sep
Actualizado: sáb., 20 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
Otro
54.91%
Accionistas
Accionistas
Proporción
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
Otro
54.91%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
30.47%
Investment Advisor
24.54%
Investment Advisor/Hedge Fund
18.34%
Individual Investor
1.85%
Research Firm
1.81%
Bank and Trust
0.12%
Private Equity
0.08%
Venture Capital
0.05%
Insurance Company
0.02%
Otro
22.71%

Participación institucional

Actualizado: dom., 5 de oct
Actualizado: dom., 5 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
203
28.26M
75.43%
-694.17K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Wynnefield Capital, Inc.
4.70M
9.16%
--
--
Jun 30, 2025
Legion Partners Asset Management, LLC
4.43M
8.63%
--
--
Jun 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
7.19%
+78.69K
+2.18%
Jun 30, 2025
325 Capital LLC
2.16M
4.21%
+1.00
+0.00%
Sep 02, 2025
Laughing Water Capital, LP
1.90M
3.7%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
3.51%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.72M
3.35%
+90.16K
+5.52%
Jun 30, 2025
The Vanguard Group, Inc.
1.61M
3.13%
+63.30K
+4.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
775.49K
1.51%
+25.00K
+3.33%
Jun 30, 2025
GrizzlyRock Capital, LLC
734.53K
1.43%
+734.53K
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.04%
WisdomTree US SmallCap Fund
Proporción0.03%
Global X Russell 2000 ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Motley Fool Next Index ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
iShares Russell 2000 Value ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI